Abdulrahman Alhajahjeh

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Abdulrahman Alhajahjeh

Dec 11, 2024, 11:27 | Blog

Dr Abdulrahman Alhajahjeh shares cost effectiveness of transplant in intermediate risk AML

Amer Zeidan shared on X: "Dr Abdulrahman Alhajahjeh did an outstanding job to present on behalf…

Dec 8, 2024, 04:20 | Insight

Amer Zeidan: Global Disparities in Characteristics and Outcomes of Leukemia Clinical Trials

Amer Zeidan, Associate Professor of Medicine at Yale University, shared an article by Abdulrahman Alhajahjeh on…

Oct 25, 2024, 16:13 | Blog

Amer Zeidan: Analyzing determinants of premature trial discontinuation in leukemia clinical trials

Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X: "Our…

Jul 7, 2024, 16:11 | Insight

Amer Zeidan: Excellent paper by Abdulrahman Alhajahjeh under mentorship of Maximilian Stahl

Amer Zeidan shared a post on X: "Another excellent paper by University of Jordan super…

Jun 18, 2024, 17:31 | Insight

Amer Zeidan: Nothing is better than training international students on research

Amer Zeidan shared a post on X: “Nothing better training international students on research. True pleasure…

All: 5 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023